UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-9328 ECOLAB INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employer incorporatio ...

Financial Data and Key Metrics Changes - The company reported a strong start in 2024 with first quarter organic sales growth of 5% and organic operating income margin expansion of 400 basis points, driving adjusted earnings per share up 52% [42][43] - The company remains on a long-term earnings growth trajectory of 12% to 15% [43] - The company anticipates full year 2024 adjusted EPS to be in the range of $6.40 to $6.70, representing a 23% to 29% increase compared to the previous year [62] Business Line Data and Key Metrics Changes - The Pest Elimination segment has been separated and is now reporting directly to the COO, achieving $1 billion in sales in 2023, with upper single-digit sales growth and double-digit organic operating income growth [1][61] - Institutional Specialty delivered double-digit sales growth and attractive operating income margins, with expectations for organic sales growth to moderate somewhat [58][62] - Life Sciences sales grew modestly despite a challenging market, indicating potential for recovery in the second half of the year [46][48] Market Data and Key Metrics Changes - The company noted that the pandemic has positively impacted the institutional and specialty business, with improved margins and customer willingness to pay more [10][11] - In Europe, the business has shown remarkable growth and margin expansion despite a difficult environment, driven by market share gains [132][133] Company Strategy and Development Direction - The company is focusing on organic growth and leveraging digital capabilities to transform its Pest Elimination business into a digital business [4][5] - The company plans to continue small bolt-on acquisitions to enhance its Pest Elimination franchise [6] - The company is committed to investing in digital and AI technology to enhance customer service and operational efficiency [66][84] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the current macroeconomic environment, indicating stability and positive trends for 2024 [24] - The company expects continued pricing and volume growth, with a focus on achieving a 20% operating income margin in the coming years [57][68] - Management highlighted the importance of maintaining strong underlying productivity while increasing investments for future growth [66][90] Other Important Information - The company is undergoing a transformation in its healthcare business, focusing on infection prevention and instrument reprocessing, with a divestiture of its surgical drapes business expected to close soon [60][48] - The company is committed to capital allocation priorities that focus on investing in the business and returning cash to shareholders [63][131] Q&A Session Summary Question: Can you provide insights on the institutional and specialty business performance? - Management acknowledged strong performance in the institutional and specialty business, attributing it to improved customer traffic and cost reductions [10][11] Question: What is the outlook for the Life Sciences business? - Management indicated that Life Sciences is showing growth in a declining market, with expectations for improvement in the second half of the year [18][46] Question: How is the company addressing the healthcare business transformation? - Management detailed steps taken to adjust the cost structure and bifurcate the healthcare business, focusing on infection prevention and digital solutions [60][28] Question: What are the growth investments being made? - Management outlined investments in growth drivers, including increasing personnel, enhancing digital capabilities, and integrating services across business lines [66][78] Question: How is the company managing pricing and volume growth? - Management expressed confidence in achieving 2% to 3% pricing and 1% to 2% volume growth, supported by strong customer value propositions [62][25]

Ecolab Inc. (ECL) reported first-quarter 2024 adjusted earnings per share (EPS) of $1.34, up 52.3% year over year. The bottom line exceeded the Zacks Consensus Estimate by 0.8%.GAAP EPS for the quarter was $1.43, up 74.4% year over year.Revenue DetailsRevenues grossed $3.75 billion in the reported quarter, up 5% year over year. The metric topped the Zacks Consensus Estimate by 0.1%.Ecolab’s organic sales increased 4.5% from the prior-year period’s level.The year-over-year uptick in the first-quarter organic ...

For the quarter ended March 2024, Ecolab (ECL) reported revenue of $3.75 billion, up 5.1% over the same period last year. EPS came in at $1.34, compared to $0.88 in the year-ago quarter.The reported revenue represents a surprise of +0.07% over the Zacks Consensus Estimate of $3.75 billion. With the consensus EPS estimate being $1.33, the EPS surprise was +0.75%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations ...

Ecolab (ECL) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.33 per share. This compares to earnings of $0.88 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 0.75%. A quarter ago, it was expected that this cleaning, food-safety and pest-control services company would post earnings of $1.54 per share when it actually produced earnings of $1.55, delivering a surprise of 0.65%.Over ...

Exhibit 99.1 News Release Investor Contact: Media Contact: Andrew Hedberg (651) 250-2185 Nigel Glennie (651) 250-2576 Cairn Clark (651) 250-2291 ECOLAB DELIVERS VERY STRONG FIRST QUARTER PERFORMANCE REPORTED DILUTED EPS $1.43; ADJUSTED DILUTED EPS $1.34, +52% INCREASED 2024 ADJUSTED DILUTED EPS OUTLOOK: $6.40 - $6.70, +23% - 29% FIRST QUARTER HIGHLIGHTS SALE OF GLOBAL SURGICAL SOLUTIONS BUSINESS ● Ecolab has entered into a definitive agreement for the sale of its global surgical solutions business to Medlin ...

Investors interested in Basic Materials stocks should always be looking to find the best-performing companies in the group. Ecolab (ECL) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Basic Materials peers, we might be able to answer that question.Ecolab is one of 240 companies in the Basic Materials group. The Basic Materials group currentl ...

Ecolab, Inc. (ECL) is scheduled to report first-quarter 2024 results on Apr 30, before the opening bell.In the last reported quarter, the company’s earnings per share (EPS) of $1.55 surpassed the Zacks Consensus Estimate by 0.7%. Over the trailing four quarters, its earnings outperformed the Zacks Consensus Estimate on all occasions, delivering an earnings surprise of 1.7%, on average.                   Let’s see how things have shaped up for Ecolab prior to this announcement.Global IndustrialThe Global Ind ...

The upcoming report from Ecolab (ECL) is expected to reveal quarterly earnings of $1.33 per share, indicating an increase of 51.1% compared to the year-ago period. Analysts forecast revenues of $3.75 billion, representing an increase of 5% year over year.Over the last 30 days, there has been an upward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this ...

Ecolab (ECL) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on April 30. On the ...